Decreased ACTL10 RNA expression levels were found in CD34+/CD38- patients (dataset GSE76004; two-tailed unpaired t-test; P<0.01; Fig. S4), whereas ACTL10 RNA expression levels were observed to be increased in CD34+/CD38+ patients with AML (dataset GSE76004; two-tailed unpaired t-test; P<0.05; Fig. S4). Here, CD34 is linked to acute myeloid leukemia.